Cell Growth & Differentiation, Vol 8, Issue 4 463-470, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells

H Sheng, J Shao, EB Hooton, M Tsujii, RN DuBois and RD Beauchamp
Department of Surgery, Vanderbilt Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2279, USA.

Rat intestinal epithelial cells (RIE-1) permanently transfected with the prostaglandin endoperoxide synthase 2 (also referred to as cyclooxygenase-2; COX-2) gene exhibit decreased cyclin D1 levels, decreased cdk4-associated kinase activity, and delayed G1 cell cycle progression, which represents a phenotype similar to that which follows transforming growth factor beta (TGF-beta) treatment. In the current study, we have found that addition of TGF-beta 1 to the parental RIE-1 cells (designated RIE-P) caused a rapid induction of COX-2 mRNA and protein. COX-2 protein levels progressively increased and reached peak levels 6 h after TGF-beta 1 addition. Cyclin D1 was decreased by 74% at 6 h and was undetectable 24 h after addition of TGF-beta 1. In RIE cells transfected with the COX-2 antisense expression vector (RIE-AS cells), TGF-beta 1 induction of COX-2 protein was reduced greater than 90%. Addition of TGF-beta 1 did not reduce the abundant cyclin D1 protein expression in the RIE-AS cells, unlike the effect in RIE-P cells. TGF-beta 1 treatment reduced peak [3H]thymidine incorporation by 60% and delayed G1/S-phase transition by at least 4 h in the RIE-P cells. In contrast, S-phase entry occurred at 16 h in RIE-AS cells and was not altered by TGF-beta 1 treatment. Restoration of cyclin D1 expression by transfection of the cyclin D1 cDNA under transcriptional control of the cytomegalovirus promoter/enhancer in the COX-2-overexpressing (RIE-S) cells decreased the time required for S-phase entry by at least 4 h and increased the peak level of [3H]thymidine incorporation. Taken together, the results demonstrate that TGF-beta 1 strongly induces COX-2 at both the mRNA and protein levels and suggest that this induction of COX-2 is involved in the down-regulation of cyclin D1 and inhibition of cell growth caused by TGF-beta 1 in rat intestinal epithelial cells.

This article has been cited by other articles:

				E. M. Poole, J. Bigler, J. Whitton, J. G. Sibert, J. D. Potter, and C. M. Ulrich Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 502 - 508. [Abstract] [Full Text] [PDF]

				C. M. Ulrich, J. Whitton, J.-H. Yu, J. Sibert, R. Sparks, J. D. Potter, and J. Bigler PTGS2 (COX-2) -765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 616 - 619. [Abstract] [Full Text] [PDF]

				H. Okano, H. Shinohara, A. Miyamoto, K. Takaori, and N. Tanigawa Concomitant Overexpression of Cyclooxygenase-2 in HER-2-Positive on Smad4-Reduced Human Gastric Carcinomas Is Associated with a Poor Patient Outcome Clin. Cancer Res., October 15, 2004; 10(20): 6938 - 6945. [Abstract] [Full Text] [PDF]

				R. Sparks, J. Bigler, J. G Sibert, J. D Potter, Y. Yasui, and C. M Ulrich TGF{beta}1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps Int. J. Epidemiol., October 1, 2004; 33(5): 955 - 961. [Abstract] [Full Text] [PDF]

				J. Zhang, P. Z. Anastasiadis, Y. Liu, E. A. Thompson, and A. P. Fields Protein Kinase C (PKC) {beta}II Induces Cell Invasion through a Ras/Mek-, PKC{iota}/Rac 1-dependent Signaling Pathway J. Biol. Chem., May 21, 2004; 279(21): 22118 - 22123. [Abstract] [Full Text] [PDF]

				H Sheng, J Shao, C M Townsend jr, and B M Evers Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells Gut, October 1, 2003; 52(10): 1472 - 1478. [Abstract] [Full Text] [PDF]

				W A Brown, S A Skinner, C Malcontenti-Wilson, D Vogiagis, and P E O'Brien Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation Gut, May 1, 2001; 48(5): 660 - 666. [Abstract] [Full Text] [PDF]

				A. McGinty, Y.-W. E. Chang, A. Sorokin, D. Bokemeyer, and M. J. Dunn Cyclooxygenase-2 Expression Inhibits Trophic Withdrawal Apoptosis in Nerve Growth Factor-differentiated PC12 Cells J. Biol. Chem., April 14, 2000; 275(16): 12095 - 12101. [Abstract] [Full Text] [PDF]

				H. Sheng, J. Shao, D. A. Dixon, C. S. Williams, S. M. Prescott, R. N. DuBois, and R. D. Beauchamp Transforming Growth Factor-beta 1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA J. Biol. Chem., February 25, 2000; 275(9): 6628 - 6635. [Abstract] [Full Text] [PDF]

				T. E. Crew, D. J.E. Elder, and C. Paraskeva A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate Carcinogenesis, January 1, 2000; 21(1): 69 - 77. [Abstract] [Full Text] [PDF]

				J. Shao, H. Sheng, R. Aramandla, M. A. Pereira, R. A. Lubet, E. Hawk, L. Grogan, I. R. Kirsch, M. K. Washington, R. D. Beauchamp, et al. Coordinate regulation of cyclooxygenase-2 and TGF-ß1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors Carcinogenesis, February 1, 1999; 20(2): 185 - 191. [Abstract] [Full Text] [PDF]

				H. Sheng, C. S. Williams, J. Shao, P. Liang, R. N. DuBois, and R. D. Beauchamp Induction of Cyclooxygenase-2 by Activated Ha-ras Oncogene in Rat-1 Fibroblasts and the Role of Mitogen-activated Protein Kinase Pathway J. Biol. Chem., August 21, 1998; 273(34): 22120 - 22127. [Abstract] [Full Text] [PDF]